Hymecromone ( DrugBank: Hymecromone )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
94原発性硬化性胆管炎1

94. 原発性硬化性胆管炎


臨床試験数 : 148 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05295680
(ClinicalTrials.gov)
November 20224/3/2022Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.A Study of Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis(HAAPS Study).Primary Sclerosing CholangitisDrug: HymecromonePaul BollykyNULLNot yet recruiting14 Years75 YearsAll24Phase 2United States